IGFL2 Activators
IGFL2 can initiate a cascade of events leading to its increased activity through various signaling pathways. Phorbol 12-myristate 13-acetate (PMA) serves as an activator of protein kinase C (PKC), which phosphorylates a suite of intracellular proteins, some of which can be involved in the regulation of IGFL2 secretion or modulation of its activity. Forskolin, by activating adenylate cyclase, leads to an elevation of cAMP levels, which in turn activates protein kinase A (PKA). PKA can then relay signals that promote the activity of IGFL2, possibly by influencing the phosphorylation status of proteins that govern its secretion or function. Ionomycin, by increasing intracellular calcium concentrations, engages calcium-dependent signaling molecules like calmodulin and calcium/calmodulin-dependent protein kinases, which can contribute to enhancing IGFL2 activity by similar means of modulating secretion or protein-protein interactions.
Isoproterenol, as a beta-adrenergic receptor agonist, elevates cAMP levels, thereby activating PKA. This activation can lead to a series of phosphorylation events that bolster IGFL2 activity. Insulin stimulates its receptor to activate the PI3K/Akt pathway, with Akt known to phosphorylate several downstream proteins that can be linked to the regulation of IGFL2. The activation of the EGF receptor by Epidermal Growth Factor triggers the MAPK/ERK pathway, which might also influence the activity of IGFL2. VEGF engages its receptors to initiate signaling through the PI3K/Akt and MAPK/ERK pathways, both of which are capable of eliciting responses that upregulate IGFL2. Hydrogen Peroxide, through its role as an oxidizing agent, can induce redox signaling, influencing transcription factors that regulate IGFL2 activity. Thrombin, via protease-activated receptors, initiates signaling cascades that can elevate IGFL2 activity. Bradykinin and Histamine, by activating their respective receptors, lead to PKC activation through the release of calcium, which can positively influence IGFL2 activity. Lastly, Estrogen binds to its receptors and can modulate signal transduction pathways, including MAPK/ERK, which are implicated in the regulation of IGFL2 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which then phosphorylates various intracellular proteins. Since IGFL2 is a secreted protein, PKC activation can lead to phosphorylation events that promote IGFL2 secretion or activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-dependent signaling pathways, including those involving calmodulin and calcium/calmodulin-dependent protein kinases, which could enhance the activity of IGFL2 by promoting its secretion or activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, activates the beta-adrenergic receptors that increase cAMP levels, leading to the activation of PKA. PKA can then potentially enhance IGFL2 activity through phosphorylation of related regulatory proteins. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor, leading to the activation of the PI3K/Akt signaling pathway. Akt can phosphorylate various proteins and may promote the activity of IGFL2 through downstream signaling effects. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen Peroxide acts as an oxidizing agent that can modulate signaling pathways through the reversible oxidation of protein cysteine residues. This redox signaling can activate transcription factors that may enhance IGFL2 activity. | ||||||
Thrombin from human plasma | 9002-04-4 | sc-471713 | 100 U | $235.00 | ||
Thrombin is a serine protease that can activate protease-activated receptors (PARs). Activation of PARs can lead to intracellular signaling cascades that potentially increase IGFL2 activity through secretion or by altering its interaction with other proteins. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin activates bradykinin receptors, leading to the release of intracellular calcium and the activation of PKC. This could promote IGFL2 activity by enhancing its secretion or through phosphorylation of associated proteins. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine binds to histamine receptors, which can result in increased intracellular calcium and activation of PKC. These events may upregulate the activity of IGFL2 by influencing its secretion or modifying its protein interactions. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Estrogen binds to estrogen receptors, which can modulate various signaling pathways, including the MAPK/ERK pathway that may lead to enhanced IGFL2 activity by affecting its secretion or the activity of proteins that IGFL2 interacts with. | ||||||